Loading...

PE/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_PECy7_090507
C57BL/6 mouse splenocytes stained with 30-F11 PE/Cyanine7
  • 30-F11_PECy7_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103113 25 µg 87 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103114 100 µg 190 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Khare A, et al. 2016. Cell Rep. 15: 1700-1714. PubMed
  2. Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
  3. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  4. Garber C, et al. 2019. Nat Neurosci. 1.802777778. PubMed
  5. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  6. Wu JH, et al. 2020. EMBO Mol Med. 12:e10154. PubMed
  7. Rodriguez de la Fuente L, et al. 2021. STAR Protoc. 2:100841. PubMed
  8. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  9. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  10. Yang AC, et al. 2020. Nature. 583:425. PubMed
  11. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  12. Yagishita Y, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  13. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  14. Wagner G, et al. 2017. Sci Rep. 7:40881. PubMed
  15. Weeden C, et al. 2017. PLoS Biol. 10.1371/journal.pbio.2000731. PubMed
  16. Hilliard K, et al. 2015. Infect Immun . 83: 4015 - 4027. PubMed
  17. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  18. Smith NR, et al. 2017. Cell Mol Gastroenterol Hepatol. 0.395138889. PubMed
  19. Zhou J, et al. 2019. Immunity. 50:403. PubMed
  20. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  21. Chang T, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006485. PubMed
  22. García-Prat L, et al. 2020. Nat Cell Biol. 22:1307. PubMed
  23. Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed
  24. Pan J, et al. 2021. Mol Ther Nucleic Acids. 26:970. PubMed
  25. Helms EJ, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  26. Huck NA, et al. 2021. J Neurosci. 41:4349. PubMed
  27. Wu Q, et al. 2021. Cancer Commun (Lond). Online ahead of prin. PubMed
  28. Ma Q, et al. 2021. Clin Transl Immunology. 10:e1300. PubMed
  29. Vila Ellis L, et al. 2020. Dev Cell. 617:52. PubMed
  30. Wilson RP, et al. 2019. PLoS Pathog. 15:e1007745. PubMed
  31. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  32. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  33. Mansouri N, et al. 2019. JCI Insight. 4:e128060. PubMed
  34. Kim YS, et al. 2021. Cell Death Dis. 12:307. PubMed
  35. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  36. Manivasagam S, et al. 2022. J Immunol. 208:1341. PubMed
  37. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  38. Fu Y, et al. 2020. Mol Ther. 1214:28. PubMed
  39. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  40. White MPJ, et al. 2020. Front Immunol. 11:1830. PubMed
  41. Saito S, et al. 2020. Nutrients. 12:. PubMed
  42. Mathews J, et al. 2014. PLoS One. 9:97707. PubMed
  43. Britschgi A, et al. 2017. Nature. 541:541-545. PubMed
  44. Valds-Mora F, et al. 2021. Cell Reports. 35(2):108945. PubMed
  45. DellOrso S, et al. 2021. STAR Protocols. 2(2):100451. PubMed
  46. Wang B, et al. 2017. EBioMedicine. 10.1016/j.ebiom.2017.03.041. PubMed
  47. Kaczmarek–Hájek K, et al. 2018. Elife. 7:e36217. PubMed
  48. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  49. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  50. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  51. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  52. Little DR, et al. 2021. Nat Commun. 12:2509. PubMed
  53. Bhopale VM, et al. 2021. J Appl Physiol (1985). 130:1604. PubMed
  54. Zheng L, et al. 2022. J Neuroinflammation. 19:128. PubMed
  55. Jiang YH, et al. 2020. J Mol Cell Cardiol. 138:115. PubMed
  56. Pan J, et al. 2020. J Neuroinflammation. 17:97. PubMed
  57. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  58. Garber C, et al. 2018. Nat Immunol. 19:151. PubMed
  59. Campanario S, et al. 2021. Front Cell Dev Biol. 8:620409. PubMed
  60. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  61. Mizuochi C, et al. 2012. PLoS One. 7:e35763. PubMed
  62. Gigliotti J, et al. 2013. J Am Soc Nephrol. 24:1451. PubMed
  63. Wang B,et al. 2017. Cell Discov.. 10.1038/celldisc.2017.36. PubMed
  64. Solanas G, et al. 2017. Cell. 170:678. PubMed
  65. Dubey LK, et al. 2019. Cell Rep. 27:2442. PubMed
  66. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  67. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  68. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  69. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  70. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  71. McGowan SE, et al. 2018. Am J Physiol Lung Cell Mol Physiol. 315:L102. PubMed
  72. Cheng HW, et al. 2019. Nat Commun. 10:1739. PubMed
  73. Cong J et al. 2018. Cell metabolism. 28(2):243-255 . PubMed
  74. Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed
  75. Fix DK, et al. 2021. Aging Cell. 20:e13448. PubMed
  76. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  77. Zhu L, et al. 2021. Stem Cell Res Ther. 12:408. PubMed
  78. Allen S, et al. 2011. J Virol. 85:11448. PubMed
  79. Jaworska K, et al. 2015. J Immunol. 194:325. PubMed
  80. Furuya Y, et al. 2015. PLoS Pathog. 11: 1005180. PubMed
  81. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  82. Cain MP, et al. 2020. Dis Model Mech. 13:00. PubMed
  83. Court AC, et al. 2020. EMBO Rep. 21:e48052. PubMed
  84. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  85. Onder L et al. 2017. Immunity. 47(1):80-92 . PubMed
  86. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  87. Kimbrough D, et al. 2018. J Mol Cell Cardiol. 119:51. PubMed
  88. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  89. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  90. Wang W, et al. 2020. Immunity. 51(6):1102-1118.e7.. PubMed
  91. Huang CH, et al. 2020. Adv Ther (Weinh). 3:. PubMed
  92. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  93. Okamura T, et al. 2021. Front Immunol. 12:669629. PubMed
  94. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  95. Basu A, et al. 2021. Cancer Immunol Res. Online ahead of print. PubMed
  96. Fennell LM, et al. 2020. EMBO J. 39:e103303. PubMed
  97. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  98. McCoy S 2015. Am J Physiol Lung Cell Mol Physiol. 309: L463-L474. PubMed
  99. Yen Y, et al. 2008. J Virol. 82:12312. PubMed
  100. Uribesalgo I, et al. 2019. EMBO Mol Med. 11:e9266. PubMed
  101. Son NH, et al. 2018. J Clin Invest. 128:4329. PubMed
  102. Ellegast JM, et al. 2022. Cancer Discov. 12:1760. PubMed
  103. Liu T, et al. 2022. Front Immunol. 13:901349. PubMed
  104. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  105. Manco R, et al. 2021. Nat Commun. 12:3074. PubMed
  106. Zuo W, et al. 2022. Cell Death Discov. 8:257. PubMed
  107. Berg AL, et al. 2022. Cancers (Basel). 14:. PubMed
  108. Ishii H, et al. 2012. Cell Death Dis. 9;3:e363. PubMed
  109. Wang F, et al. 2021. Cell. 184(2):422-440.e17. PubMed
  110. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  111. Kellish P, et al. 2019. J Clin Invest. 130:2279. PubMed
  112. Magri G et al. 2017. Immunity. 47(1):118-134 . PubMed
  113. Sela Y, et al. 2021. Elife. 10: . PubMed
  114. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  115. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  116. Pascual G, et al. 2021. Nature. 599:485. PubMed
  117. Kolodziejczyk AA, et al. 2020. Nat Med. 26:1899. PubMed
  118. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  119. Chu X, et al. 2021. Front Cell Dev Biol. 9:671841. PubMed
  120. Shafiei-Jahani P, et al. 2021. Nat Commun. 12:2526. PubMed
  121. Wu X, et al. 2016. Sci Rep. 6:18685. PubMed
  122. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  123. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  124. van Gastel N, et al. 2020. Cell Metabolism. 32(3):391-403.e6. PubMed
  125. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  126. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  127. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  128. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  129. Jin L, et al. 2022. J Immunol Res. 2022:7222638. PubMed
  130. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  131. Evgin L, et al. 2022. Sci Transl Med. 14:eabn2231. PubMed
  132. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  133. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  134. Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed
  135. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  136. Abdelfattah N, et al. 2022. Nat Commun. 13:767. PubMed
  137. Li J, et al. 2020. Development. . PubMed
  138. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  139. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  140. Magness S, et al. 2013. Am J Physiol Gastrointest Liver Physiol. 305:542. PubMed
  141. Wang W, et al. 2021. STAR Protocols. 2(3):100756. PubMed
  142. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  143. Liu YG, et al. 2019. FASEB J. 33:5018. PubMed
  144. Mohammadpour H, et al. 2021. Cell Rep. 37:109883. PubMed
  145. Zhu S, et al. 2022. EBioMedicine. 80:104060. PubMed
  146. Sung PS, et al. 2022. JCI Insight. :. PubMed
  147. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  148. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  149. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  150. Smith NR, et al. 2018. Cell Mol Gastroenterol Hepatol. 6:79. PubMed
  151. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  152. Nian Z, et al. 2021. Clin Cancer Res. 27:6026. PubMed
  153. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  154. Hakim R, et al. 2021. J Neurosci. 41:8441. PubMed
  155. Ognjenovic NB, et al. 2020. Dev Cell. 55:544. PubMed
  156. Gu H, et al. 2021. Elife. 10:. PubMed
  157. Hendee K, et al. 2021. Aging (Albany NY). 13:7781. PubMed
  158. Issah Y, et al. 2021. Elife. 10:. PubMed
  159. Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
  160. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  161. Béchade C, et al. 2020. Glia. . PubMed
  162. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  163. Kelley WJ, et al. 2022. JCI Insight. :. PubMed
  164. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  165. Fan X, et al. 2020. Acta Physiol (Oxf). 230:e13475. PubMed
  166. Fang Y, et al. 2022. Development. 149:. PubMed
  167. Gong P, et al. 2022. Cell Death Discov. 8:466. PubMed
  168. Sheng J, et al. 2021. eLife. 10:00. PubMed
  169. Moreno M et al. 2014. The Journal of Neuroscience. 34(24):8175-85 . PubMed
  170. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  171. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  172. Oh J, et al. 2021. Clin Cancer Res. 27:4781. PubMed
  173. Li Q, et al. 2022. J Biol Chem. :101753. PubMed
  174. Dong H, et al. 2022. Nat Metab. 4:90. PubMed
  175. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  176. Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
  177. Hussein M, et al. 2015. PLoS One. 10: 0135218. PubMed
  178. Gigliotti J, et al. 2015. J Am Soc Nephrol. 26: 2470 - 2481. PubMed
  179. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  180. Gerner-Mauro KN, et al. 2020. Proc Natl Acad Sci U S A. 117:12182. PubMed
  181. Kimmel JC, et al. 2021. Cell Reports. 35(4):109046. PubMed
  182. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  183. Ghosh S, et al. 2019. Commun Biol. 0.325. PubMed
  184. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  185. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  186. Wu H, et al. 2020. Cell. 180(1):107-121.e17.. PubMed
  187. Muri J, et al. 2020. Cell Reports. 30(13):4399-4417. PubMed
  188. Chithanathan K, et al. 2022. Biology (Basel). 11:. PubMed
  189. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  190. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  191. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  192. Ren X, et al. 2021. Cell Death Dis. 12:484. PubMed
RRID
AB_312978 (BioLegend Cat. No. 103113)
AB_312979 (BioLegend Cat. No. 103114)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD45

  • Biotin anti-mouse CD45

  • FITC anti-mouse CD45

  • PE anti-mouse CD45

  • PE/Cyanine5 anti-mouse CD45

  • Purified anti-mouse CD45

  • PE/Cyanine7 anti-mouse CD45

  • APC/Cyanine7 anti-mouse CD45

  • Alexa Fluor® 488 anti-mouse CD45

  • Alexa Fluor® 647 anti-mouse CD45

  • Pacific Blue™ anti-mouse CD45

  • Alexa Fluor® 700 anti-mouse CD45

  • PerCP/Cyanine5.5 anti-mouse CD45

  • PerCP anti-mouse CD45

  • Alexa Fluor® 594 anti-mouse CD45

  • Brilliant Violet 421™ anti-mouse CD45

  • Brilliant Violet 570™ anti-mouse CD45

  • Brilliant Violet 510™ anti-mouse CD45

  • Brilliant Violet 605™ anti-mouse CD45

  • Purified anti-mouse CD45 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse CD45

  • Brilliant Violet 711™ anti-mouse CD45

  • Brilliant Violet 785™ anti-mouse CD45

  • Brilliant Violet 650™ anti-mouse CD45

  • APC/Fire™ 750 anti-mouse CD45

  • Brilliant Violet 750™ anti-mouse CD45

  • TotalSeq™-A0096 anti-mouse CD45

  • TotalSeq™-B0096 anti-mouse CD45

  • Ultra-LEAF™ Purified anti-mouse CD45

  • Spark Blue™ 550 anti-mouse CD45

  • Spark NIR™ 685 anti-mouse CD45

  • TotalSeq™-C0096 anti-mouse CD45

  • Spark YG™ 570 anti-mouse CD45

  • PE/Fire™ 640 anti-mouse CD45

  • APC/Fire™ 810 anti-mouse CD45

  • PE/Fire™ 700 anti-mouse CD45

  • Spark Violet™ 538 anti-mouse CD45

  • Spark YG™ 593 anti-mouse CD45

  • Spark Blue™ 574 anti-mouse CD45 Antibody
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account